These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 5158530

  • 1. [Evaluation in clinical trials of some drug associations. (L-dopa, neuroleptics and lithium carbonate)].
    Longo V, Kemali D, Pacini A, Bertolino A, Lamura G.
    Boll Soc Ital Biol Sper; 1971 Aug 15; 47(15):470-2. PubMed ID: 5158530
    [No Abstract] [Full Text] [Related]

  • 2. [Present-day possibilities of relieving post-neuroleptic extrapyramidal symptoms].
    Wasik A.
    Psychiatr Pol; 1973 Aug 15; 7(1):51-6. PubMed ID: 4715833
    [No Abstract] [Full Text] [Related]

  • 3. [Neuroleptics, thymoleptics and tranquilizers in neurological therapy].
    Hertrich O.
    Bibl Psychiatr Neurol; 1969 Aug 15; 139():88-113. PubMed ID: 4400242
    [No Abstract] [Full Text] [Related]

  • 4. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A, Nardini M, Sorgona F.
    Sist Nerv; 1970 Aug 15; 22(5):273-85. PubMed ID: 5514245
    [No Abstract] [Full Text] [Related]

  • 5. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs].
    Ferrari P, Robotti E, Nardini M.
    Boll Chim Farm; 1972 Oct 15; 111(10):610-5. PubMed ID: 4566407
    [No Abstract] [Full Text] [Related]

  • 6. Ethylbenzatropine for acute neurological and mental side effects after tranquillisers.
    Molcan J, Floreánová L, Polák L.
    Act Nerv Super (Praha); 1972 Oct 15; 14(2):97. PubMed ID: 5040183
    [No Abstract] [Full Text] [Related]

  • 7. Methylphenidate in tardive dyskinesia.
    Fann WE, Davis JM, Wilson IC.
    Am J Psychiatry; 1973 Aug 15; 130(8):922-4. PubMed ID: 4577471
    [No Abstract] [Full Text] [Related]

  • 8. Drug therapy.
    Stone WN, Hofling CK, Winslow WW.
    Prog Neurol Psychiatry; 1971 Aug 15; 26():529-51. PubMed ID: 4274994
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical trial of tropatepine chlorhydrate as a corrector of syndromes due to neuroleptics].
    Delaunay J, Guibert S.
    Ann Med Psychol (Paris); 1976 Jan 15; 1(1):144-7. PubMed ID: 970819
    [No Abstract] [Full Text] [Related]

  • 10. Drug therapy.
    Stone WN, Hofling CK, Winslow WW.
    Prog Neurol Psychiatry; 1968 Jan 15; 23():563-81. PubMed ID: 4890081
    [No Abstract] [Full Text] [Related]

  • 11. [Delayed-action neuroleptics (sustained-release neuroleptics). Indications, advantages and side effects].
    Predescu V, Nica-Udangiu St.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1975 Jan 15; 20(4):287-96. PubMed ID: 1085475
    [No Abstract] [Full Text] [Related]

  • 12. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H, Vereecken JL, Tanghe A.
    Psychiatr Neurol Neurochir; 1973 Jan 15; 76(4):251-9. PubMed ID: 4581374
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical psychopharmacology in 1971].
    Vinar O.
    Act Nerv Super (Praha); 1972 Jan 15; 14(2):141-60. PubMed ID: 4339153
    [No Abstract] [Full Text] [Related]

  • 14. [Iron, transferrin, copper and ceruloplasmin of the serum and cerebrospinal fluid in extrapyramidal diseases and primary myopathies. Study in basic conditions and in Parkinsonism after treatment with dopaminergic agents (L-dopa, L-dopa + RO 4-4602, amantadine)].
    Campanella G, Carrieri P, Romito D, Pasqual-Marsettin E.
    Acta Neurol (Napoli); 1973 Jan 15; 28(1):1-34. PubMed ID: 4704396
    [No Abstract] [Full Text] [Related]

  • 15. The neuroleptics. 10. Therapeutic problems.
    Barahona-Fernandes HJ, Cazzullo CL, Cocchi A, Denber HC, Freyhan FA, Klerman GL, Köknel O, Levine J, Saarma J, Sarteschi P, Vinar O, Wittenborn JR.
    Mod Probl Pharmacopsychiatry; 1970 Jan 15; 5():148-56. PubMed ID: 4949818
    [No Abstract] [Full Text] [Related]

  • 16. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R.
    Med Klin; 1969 Aug 15; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract] [Full Text] [Related]

  • 17. [Use of new drug treatments in child psychiatry (long-acting neuroleptics, antidepressive agents and lithium)].
    Dugas M, Velin J, Guériot C, Frohwirth C.
    Cah Med; 1973 Sep 15; 14(9):711-6. PubMed ID: 4779496
    [No Abstract] [Full Text] [Related]

  • 18. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C, Dimascio A, Demirgian E.
    Curr Ther Res Clin Exp; 1972 May 15; 14(5):246-51. PubMed ID: 4623975
    [No Abstract] [Full Text] [Related]

  • 19. [A new synthetic antiparkinsonian drug, tropatepine hydrochloride in extrapyramidal syndromes induced by neuroleptics].
    Lambert A, dachary JM, Marie C, Oules J, Pagot R, Sales M, Vauterin C.
    Encephale; 1976 May 15; 2(2):115-21. PubMed ID: 776591
    [Abstract] [Full Text] [Related]

  • 20. [Progressive extra-pyramidal disorder in 2 young brothers. Remarkable effects of treatment with L-dopa].
    Castaigne P, Rondot P, Ribadeau-Dumas JL, Saïd G.
    Rev Neurol (Paris); 1971 Feb 15; 124(2):162-6. PubMed ID: 5564861
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.